PBYI PUMA BIOTECHNOLOGY, INC.

Nasdaq pumabiotechnology.com


$ 5.48 $ 0.06 (1.11 %)    

Friday, 17-Oct-2025 15:59:58 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 5.47
$ 5.38
$ 5.10 x 100
$ 5.65 x 85
$ 5.34 - $ 5.57
$ 2.32 - $ 6.07
517,788
na
275.53M
$ 0.87
$ 5.69
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-27-2025 12-31-2024 10-K
4 11-07-2024 09-30-2024 10-Q
5 08-01-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-29-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 03-02-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 03-03-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 03-01-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 02-28-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-09-2019 06-30-2019 10-Q
26 05-10-2019 03-31-2019 10-Q
27 03-01-2019 12-31-2018 10-K
28 11-05-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-09-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-01-2017 12-31-2016 10-K
36 11-09-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 02-29-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 puma-biotechnology-affirms-fy2025-sales-guidance-of-212000m-222000m-vs-217800m-est

Puma Biotechnology (NASDAQ:PBYI) affirms FY2025 sales outlook from $212.000 million-$222.000 million to $212.000 million-$222.0...

 puma-biotechnology-sees-q3-sales-48000m-51000m-vs-60000m-est

Puma Biotechnology (NASDAQ:PBYI) sees Q3 sales of $48.000 million-$51.000 million vs $60.000 million analyst estimate.

 puma-biotechnology-q2-adj-eps-015-beats-010-estimate-sales-4920m-miss-5075m-estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0...

 puma-biotechnology-q1-adj-eps-010-beats-002-estimate-sales-4600m-beat-4455m-estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.10 per share which beat the analyst consensus estimate of $(...

 hc-wainwright--co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price t...

 puma-biotechnology-sees-q1-sales-42500m-45500m-vs-4750m-est

Puma Biotechnology (NASDAQ:PBYI) sees Q1 sales of $42.500 million-$45.500 million vs $47.50 million analyst estimate.

 puma-biotechnology-sees-fy2025-sales-212000m-222000m-vs-20790m-est

Puma Biotechnology (NASDAQ:PBYI) sees FY2025 sales of $212.000 million-$222.000 million vs $207.90 million analyst estimate.

 puma-biotechnology-q4-adj-eps-043-beats-010-estimate-sales-5910m-beat-5250m-estimate

Puma Biotechnology (NASDAQ:PBYI) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0...

 hc-wainwright--co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price t...

 hc-wainwright--co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price t...

 hc-wainwright--co-reiterates-buy-on-puma-biotechnology-maintains-7-price-target

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION